{"id":"arry-403-glucokinase-activator-oral","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Activates glucokinase, an enzyme involved in glucose metabolism, to improve glycemic control.","oneSentence":"Glucokinase activator","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T04:54:44.612Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT00952198","phase":"PHASE1","title":"A Safety Study of ARRY-403 in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Array Biopharma, now a wholly owned subsidiary of Pfizer","startDate":"2009-08","conditions":"Type 2 Diabetes","enrollment":128},{"nctId":"NCT00859755","phase":"PHASE1","title":"A Safety Study of ARRY-403 in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Array BioPharma","startDate":"2009-03","conditions":"Type 2 Diabetes","enrollment":41}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"ARRY-403, glucokinase activator; oral","genericName":"ARRY-403, glucokinase activator; oral","companyName":"Array BioPharma","companyId":"array-biopharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucokinase activator Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}